Hideyuki Nakashima

ナカシマヒデユキ | Hideyuki Nakashima

Homepage URL (1)： http://kaken.nii.ac.jp/d/r/30437032.ja.html

Research field (1)： Oral medicine (pathology)

Papers (14)：

Itaru Sato, Masanari Umemura, Kenji Mitsudo, Mitomu Kioi, Hideyuki Nakashima, Toshinori Iwai, Xianfeng Feng, Kayoko Oda, Akiyoshi Miyajima, Ayako Makino, et al. Hyperthermia generated with ferucarbotran (Resovist(A (R))) in an alternating magnetic field enhances cisplatin-induced apoptosis of cultured human oral cancer cells. JOURNAL OF PHYSIOLOGICAL SCIENCES. 2014. 64. 3. 177-183
Kenji Mitsudo, Toshiyuki Koizumi, Masaki Iida, Toshinori Iwai, Hideyuki Nakashima, Senri Oguri, Mitomu Kioi, Makoto Hirota, Izumi Koike, Masaharu Hata, et al. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: Analysis of therapeutic results in 112 cases. RADIOTHERAPY AND ONCOLOGY. 2014. 111. 2. 306-310
Hall B, Nakashima H, Sun ZJ, Sato Y, Bian Y, Husain SR, Puri RK, Kulkarni AB. Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling. Journal of translational medicine. 2013. 11. 45
Hideyuki Nakashima, Kotaro Miyake, Christopher R. Clark, Joseph Bekisz, Joel Finbloom, Syed R. Husain, Samuel Baron, Raj K. Puri, Kathryn C. Zoon. Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors. CANCER IMMUNOLOGY IMMUNOTHERAPY. 2012. 61. 7. 1081-1092
Hideyuki Nakashima, Syed R. Husain, Raj K. Puri. IL-13 receptor-directed cancer vaccines and immunotherapy. IMMUNOTHERAPY. 2012. 4. 4. 443-451

ｍore...

MISC (2)：

Work history (1)：

2012 - 横浜市立大学大学病院その他

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page